Equity Profile

MEDP

Medpace Holdings, Inc.

Health CareLife Sciences Tools & Services$16.2B

Jul20Mon

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Medpace Holdings, Inc. is a leading contract research organization that provides comprehensive services to the pharmaceutical and biotechnology industries....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

$4.00

Revenue

Revenue growth reflects the company's ability to attract and retain clients in a competitive market.

$690M

Wall Street expectations, options signals, track record, and call prep available with Pro.

MEDP Q2-2026 Earnings Preview

Context

Company Snapshot

Medpace Holdings, Inc. is a leading contract research organization that provides comprehensive services to the pharmaceutical and biotechnology industries. With a focus on life sciences tools and services, Medpace plays a crucial role in helping companies bring new drugs to market efficiently and effectively.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+12.59%

Avg Stock Reaction

-0.46%

Last Quarter Recap

In Q1-2026, Medpace reported an EPS of $4.28, exceeding expectations by 14.53%. However, the stock declined by 1.25% the following day, indicating market caution despite strong earnings.

Management Promises & Guidance

Continued focus on expanding service offerings.
Commitment to maintaining high client satisfaction.
Plans to enhance operational efficiency.

Expectations

Wall Street Expectations

Analysts are generally optimistic about Medpace's upcoming earnings, expecting solid EPS and revenue figures. However, there is caution due to past stock reactions following earnings beats.

Bull Case

If Medpace exceeds EPS and revenue expectations, it could signal strong demand for its services and lead to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet expectations, it could raise concerns about future growth prospects and negatively impact the stock price.

Key Metrics to Watch

EPS

$4.00

Earnings per share is a key indicator of the company's profitability and financial health.

Revenue

$690M

Revenue growth reflects the company's ability to attract and retain clients in a competitive market.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS exceed $4.00, and by how much?

A strong EPS figure could indicate robust demand for Medpace's services and positively influence investor sentiment.

What is the revenue outlook for the next quarter?

Guidance on future revenue will be critical for assessing the company's growth trajectory and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate the potential for revenue growth due to new client acquisitions and expanding service offerings.

Supporting Evidence

Past earnings surprises indicate strong operational capabilities that may not be fully reflected in current estimates.

The options market suggests a significant move, indicating that investors expect more volatility than the consensus reflects.

Key Risk

If revenue exceeds $706M, it could challenge the current bearish sentiment and shift market expectations.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it will provide insights into Medpace's ability to sustain growth amidst market challenges.

Bull Confirmed If

An EPS of $4.10 or higher would confirm the bullish outlook and suggest strong operational performance.

Bear Confirmed If

An EPS below $3.80 would raise concerns about the company's growth and profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±20.52%

Historical Avg

±1.5%

Pricing rich

The options market is pricing in a significant potential move in the stock following the earnings report, suggesting heightened volatility.

Options are pricing ±20.5% while MEDP has averaged ±1.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

80.4%

Calls (2K)P/C Ratio: 0.20Puts (4K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Medpace beats expectations and raises guidance, history suggests a potential stock increase of around 1.49% on the day.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further clarity from management.

Miss

A miss on EPS could lead to a decline in stock price, with historical patterns suggesting a potential drop of around 1.49%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new client contracts or partnerships.
2Management's commentary on operational efficiency improvements.
3Insights into market demand for clinical trial services.
4Future guidance on revenue growth and market expansion.
5Responses to competitive pressures in the life sciences sector.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

ICICI Bank Limited

Company Snapshot

Medpace Holdings, Inc. is a leading contract research organization that provides comprehensive services to the pharmaceutical and biotechnology industries....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

$4.00

Revenue

Revenue growth reflects the company's ability to attract and retain clients in a competitive market.

$690M

Wall Street expectations, options signals, track record, and call prep available with Pro.

MEDP Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+12.59%

Avg Stock Reaction

-0.46%

Last Quarter Recap

In Q1-2026, Medpace reported an EPS of $4.28, exceeding expectations by 14.53%. However, the stock declined by 1.25% the following day, indicating market caution despite strong earnings.

Management Promises & Guidance

Continued focus on expanding service offerings.
Commitment to maintaining high client satisfaction.
Plans to enhance operational efficiency.

Expectations

Wall Street Expectations

Analysts are generally optimistic about Medpace's upcoming earnings, expecting solid EPS and revenue figures. However, there is caution due to past stock reactions following earnings beats.

Bull Case

If Medpace exceeds EPS and revenue expectations, it could signal strong demand for its services and lead to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet expectations, it could raise concerns about future growth prospects and negatively impact the stock price.

Key Metrics to Watch

EPS

$4.00

Earnings per share is a key indicator of the company's profitability and financial health.

Revenue

$690M

Revenue growth reflects the company's ability to attract and retain clients in a competitive market.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS exceed $4.00, and by how much?

A strong EPS figure could indicate robust demand for Medpace's services and positively influence investor sentiment.

What is the revenue outlook for the next quarter?

Guidance on future revenue will be critical for assessing the company's growth trajectory and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate the potential for revenue growth due to new client acquisitions and expanding service offerings.

Supporting Evidence

Past earnings surprises indicate strong operational capabilities that may not be fully reflected in current estimates.

The options market suggests a significant move, indicating that investors expect more volatility than the consensus reflects.

Key Risk

If revenue exceeds $706M, it could challenge the current bearish sentiment and shift market expectations.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it will provide insights into Medpace's ability to sustain growth amidst market challenges.

Bull Confirmed If

An EPS of $4.10 or higher would confirm the bullish outlook and suggest strong operational performance.

Bear Confirmed If

An EPS below $3.80 would raise concerns about the company's growth and profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±20.52%

Historical Avg

±1.5%

Pricing rich

The options market is pricing in a significant potential move in the stock following the earnings report, suggesting heightened volatility.

Options are pricing ±20.5% while MEDP has averaged ±1.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

80.4%

Calls (2K)P/C Ratio: 0.20Puts (4K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Medpace beats expectations and raises guidance, history suggests a potential stock increase of around 1.49% on the day.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further clarity from management.

Miss

A miss on EPS could lead to a decline in stock price, with historical patterns suggesting a potential drop of around 1.49%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new client contracts or partnerships.
2Management's commentary on operational efficiency improvements.
3Insights into market demand for clinical trial services.
4Future guidance on revenue growth and market expansion.
5Responses to competitive pressures in the life sciences sector.